Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DocMorris AG

Market Cap 413M 514M 448M 388M 727M 48.45B 732M 4.91B 1.91B 23.88B 1.93B 1.89B 82.76B P/E 2026 *
-5.35x
P/E 2027 * -9.6x
Enterprise Value 615M 765M 667M 578M 1.08B 72.13B 1.09B 7.31B 2.84B 35.55B 2.87B 2.81B 123B EV / Sales 2026 *
0.5x
EV / Sales 2027 * 0.48x
Free-Float
66.94%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2022
Director of Finance/CFO 56 01/10/2024
Chief Tech/Sci/R&D Officer - 01/11/2024
Director TitleAgeSince
Chairman 68 28/04/2022
Director/Board Member 53 23/05/2019
Director/Board Member 56 01/01/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 521M
-0.90%-7.58%-16.63%-35.60% 14.44B
-1.79%-5.17%-29.94%-36.17% 6.93B
-0.06%-2.07%-17.27%-14.72% 5.74B
+0.61%-5.82%-18.74%-37.12% 3.55B
-0.33%-0.85%-34.84%-13.22% 3.37B
-1.24%+0.16%-24.09%-45.68% 3.35B
-2.28%-1.56%+115.50% - 2.75B
+0.50%-1.82%+1.25%-44.00% 2.71B
-0.49%-0.54%-15.59%-1.59% 2.58B
Average -0.60%-2.59%-4.48%-28.51% 5.05B
Weighted average by Cap. -0.76%-3.73%-11.69%-30.51%

Financials

2026 *2027 *
Net sales 1.22B 1.52B 1.32B 1.15B 2.14B 143B 2.16B 14.48B 5.62B 70.4B 5.69B 5.57B 244B 1.37B 1.7B 1.48B 1.29B 2.41B 161B 2.42B 16.28B 6.32B 79.11B 6.39B 6.26B 274B
Net income -84.17M -105M -91.31M -79.17M -148M -9.88B -149M -1B -389M -4.87B -393M -385M -16.87B -48.29M -60.12M -52.38M -45.42M -84.97M -5.67B -85.57M -574M -223M -2.79B -226M -221M -9.68B
Net Debt 202M 251M 219M 190M 355M 23.68B 358M 2.4B 932M 11.67B 943M 923M 40.45B 241M 300M 261M 226M 424M 28.24B 427M 2.86B 1.11B 13.92B 1.12B 1.1B 48.24B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
9
Last Close Price
8.515CHF
Average target price
7.494CHF
Spread / Average Target
-11.99%

Quarterly revenue - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!